Company Monitoring Page for Novartis

latest headlines for company on cafepharma

P&G investors wish for CEO Joe Jimenez as outgoing Novartis chief joins board
Fierce Pharma
Tue, 12/19/17 - 10:20 am
Tags:
P&G, Novartis, Pharma CEOs, Joe Jimenez
What’s the big hurry Novartis? Pharma giant scores a PRV shortcut for $130M
Endpoints
Mon, 12/18/17 - 10:02 am
Tags:
Novartis, priority review vouchers, Ultragenyx
Pfizer takes on Novartis, Lilly with Xeljanz psoriatic arthritis approval
Fierce Pharma
Fri, 12/15/17 - 11:27 pm
Tags:
Pfizer, Novartis, Eli Lilly, Xeljanz, psoriatic arthritis
Novartis oncology CEO Bruno Strigini is calling it quits
Endpoints
Fri, 12/15/17 - 10:09 am
Tags:
Novartis, oncology, Bruno Strigini
ASH 2017: What you missed
BioPharma Dive
Wed, 12/13/17 - 06:35 pm
Tags:
ASH17, Biomarin, Spark Therapeutics, Gilead Sciences, Novartis, Juno Therapeutics, AbbVie, Roche, JNJ
ASH 2017: CAR-T Wallops Blood Cancer
Motley Fool
Tue, 12/12/17 - 11:16 am
Tags:
ASH2017, CAR-T, gene therapy, Novartis, Kymriah, Yescarta, Gilead Sciences, Juno Therapeutics, JCAR017
#ASH17: How does Novartis’ Kymriah DLBCL data stack up heading straight to a CAR-T showdown with Gilead?
Endpoints
Sun, 12/10/17 - 11:10 am
Tags:
ASH17, Novartis, Kymriah, DLBCL, CAR-T, diffuse large B-cell lymphoma
NICE nods for AbbVie in hep C and Novartis in lung cancer
Pharma Times
Sun, 12/10/17 - 09:53 am
Tags:
NICE, AbbVie, hepatitis C, Maviret, Novartis, Zykadia, ALK-positive non-small cell lung cancer
Novartis seeks to revive Neulasta biosim prospects with data showing it matches Amgen’s blockbuster
Fierce Pharma
Fri, 12/8/17 - 10:41 am
Tags:
Novartis, Neulasta, biosimilars, Amgen, Sandoz, FDA
Roche, Novartis' Italian heads risk trial for alleged market rigging: sources
Yahoo/Reuters
Fri, 12/8/17 - 10:00 am
Tags:
Roche, Novartis, Italy, Avastin, Lucentis, marketing manipulation
In Young Women, Kisqali Slows Metastatic Breast Cancer And Relieves Symptoms
Forbes
Thu, 12/7/17 - 09:10 am
Tags:
Novartis, Kisqali, metastatic breast cancer
Lilly's Taltz takes Cosentyx rivalry into psoriatic arthritis with new FDA nod
Fierce Pharma
Tue, 12/5/17 - 09:30 am
Tags:
Eli Lilly, Taltz, Novartis, Cosentyx, FDA, psoriatic arthritis
Novartis looks at offloading its generic pills business in U.S. as market continues to decline
Fierce Pharma
Mon, 12/4/17 - 11:39 am
Tags:
Novartis, generics, Sandoz, M&A
Anti-aging startup ResTORbio gets $40M to fuel Phase IIb study
Endpoints
Thu, 11/30/17 - 11:03 am
Tags:
anti-aging, clinical trials, ResTORbio, Novartis, RTB101
Incoming Novartis CEO On $475,000 Cancer Therapy: 'No Question That The List Price Raises Eyebrows'
Forbes
Thu, 11/30/17 - 09:56 am
Tags:
Novartis, drug pricing, cancer, Kymriah, Pharma CEOs, Vas Narasimhan
One big Novartis takeaway from Entresto's slow start? Heart failure doesn't work like oncology
Fierce Pharma
Wed, 11/29/17 - 11:40 am
Tags:
Novartis, Entresto, drug launches, heart failure, oncology
Novartis looks to poach Advair patients with positive Ultibro switching data
Fierce Pharma
Mon, 11/27/17 - 10:42 am
Tags:
Novartis, Advair, Ultibro Breezhaler, GSK, COPD
With Novartis closing in, Regeneron scraps Eylea combo drug in a major setback
Endpoints
Mon, 11/27/17 - 09:18 am
Tags:
Novartis, Regeneron, Eylea, RTH258, nesvacumab, Bayer
Pfizer's Ibrance, Novartis' Kisqali go to battle in England after discounts twin NICE recommendations
Fierce Pharma
Thu, 11/16/17 - 11:07 am
Tags:
Pfizer, Ibrance, Novartis, Kisqali, England, breast cancer, UK, NICE
What to expect from Vas Narasimhan, next Novartis CEO
GoinPharma
Tue, 11/14/17 - 07:46 am
Tags:
Novartis, Pharma CEOs, Vas Narasimhan

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.